U.S. Plant-based Excipients Market Size & Outlook
U.S. plant-based excipients market, 2018-2030 (US$M)
Related Markets
U.S. plant-based excipients market highlights
- The U.S. plant-based excipients market generated a revenue of USD 659.5 million in 2023 and is expected to reach USD 881.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.2% from 2024 to 2030.
- In terms of segment, carbohydrates was the largest revenue generating chemical nature in 2023.
- Carbohydrates is the most lucrative chemical nature segment registering the fastest growth during the forecast period.
Plant-based excipients market data book summary
| Market revenue in 2023 | USD 659.5 million |
| Market revenue in 2030 | USD 881.5 million |
| Growth rate | 4.2% (CAGR from 2023 to 2030) |
| Largest segment | Carbohydrates |
| Fastest growing segment | Carbohydrates |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
| Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.4% of the global plant-based excipients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. plant-based excipients market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 79.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plant-based Excipients Market Scope
Plant-based Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. plant-based excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 21.11% in 2023. Horizon Databook has segmented the U.S. plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical industry in the U.S. is mature and represents a large population of prescription drug users. According to the Health Policy Institute, around 66% of U.S. adults take prescription drugs, the leading drug classes being antihypertensive, pain relief, and mental health drugs.
All these factors are improving the demand for drugs and thus supporting the demand for plant-based excipients in the region. This is expected to improve the demand for plant-based excipients in the U.S. market during the forecast period.
In September 2022, the U.S. FDA launched the Pilot Program for the Review of Innovation and Modernization of Excipients. The program emphasized creating a new pathway for manufacturers to obtain FDA review of novel excipients before their use in drug formulations.
Reasons to subscribe to U.S. plant-based excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. plant-based excipients market databook
-
Our clientele includes a mix of plant-based excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. plant-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into U.S. plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. plant based excipients market size, by chemical nature, 2018-2030 (US$M)
U.S. Plant-based Excipients Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
